ConjuStar Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $13.7M

  • Investors
  • 4

ConjuStar General Information

Description

Manufacturer of biotechnology products intended for anti tumour drug development. The company researches and develops peptide drug conjugates (PDC), anti tumour drug candidates, targeted cancer therapies, clinical stage biologics and oncology research services, thereby enabling the treatment of advanced solid tumours.

Contact Information

Website
conjustar.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor, Building 2
  • Number 367 Shengrong Road, Pudong New Area
  • Tianjin, 300000
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 3rd Floor, Building 2
  • Number 367 Shengrong Road, Pudong New Area
  • Tianjin, 300000
  • China
+86 021

ConjuStar Timeline

2023202420252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ConjuStar Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 16-Jan-2025 $13.7M Completed Generating Revenue
6. Early Stage VC 27-Mar-2024 Completed Generating Revenue
5. Secondary Transaction - Private 27-Mar-2024 Completed Generating Revenue
4. Later Stage VC 29-Jan-2024 Completed Generating Revenue
3. Early Stage VC 21-Feb-2023 Completed Generating Revenue
2. Seed Round 21-Feb-2022 $7.08M $7.08M Completed Generating Revenue
1. Joint Venture 21-Feb-2022 Completed Generating Revenue
To view ConjuStar’s complete valuation and funding history, request access »

ConjuStar Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Zhuhai Gree Financial Investment Venture Capital Minority
Zhuhai Gree Venture Capital Company Corporate Venture Capital Minority
Fosun Health Capital Corporate Venture Capital Minority
WuXi AppTec Corporation Minority
To view ConjuStar’s complete investors history, request access »

ConjuStar FAQs

  • When was ConjuStar founded?

    ConjuStar was founded in 2022.

  • Where is ConjuStar headquartered?

    ConjuStar is headquartered in Tianjin, China.

  • What industry is ConjuStar in?

    ConjuStar’s primary industry is Drug Discovery.

  • Is ConjuStar a private or public company?

    ConjuStar is a Private company.

  • What is ConjuStar’s current revenue?

    The current revenue for ConjuStar is .

  • How much funding has ConjuStar raised over time?

    ConjuStar has raised $41.5M.

  • Who are ConjuStar’s investors?

    Zhuhai Gree Financial Investment, Zhuhai Gree Venture Capital Company, Fosun Health Capital, and WuXi AppTec have invested in ConjuStar.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process